The Latest
-
Why the share price of this top dividend share just sank 6%
-
AstraZeneca gets first supply deals for COVID vaccine, eyes late stage trials
-
Samsung Takes Another Step in $116 Billion Plan to Take on TSMC
-
Stock Futures Slip With Worsening U.S.-China Rift: Markets Wrap